Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Proteinuria in Diabetic Patients in a Primary Health Care Setting in Sarawak

Wong, J.S., (2005) Proteinuria in Diabetic Patients in a Primary Health Care Setting in Sarawak. Medical Journal of Malaysia, 60 (2). pp. 146-150. ISSN 0300-5283

Full text not available from this repository.

Affiliations

Sarawak General Hospital, Dept. of Medicine

Abstract

Diabetic nephropathy is now the number one cause of end stage renal failure in Malaysia. This places a huge burden on patients and the health care syatem especially in developing countries with limited health care resources, such as in Sarawak in East Malaysia. This study describes the prevalence of proteinuria/microalbuminuria in diabetic patients treated in Klinik Kesihatan Tanah Puteh. Early detection of proteinuria/ microalbuminuria allows remedial measures to be taken to retard the progression of nephropathy. Forty-eight percent of the cases had proteinuria and microalbuminuria was found in 16%. Seventy-eight percent of cases with Proteinuria were on treatment with angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers. Seventy-five percent of patients had hypertension but only 6% achieved the targeted BP of <130/80 mmHg.

Item Type:Journal
Keywords:Diabetic nephropathy, Proteinuria, Microalbuminuria, Primary health care, Sarawak, Malaysia
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:5780

1. Lim TO. Lim YN, Lee DG. Tenth report of the Malaysian Dialysis and Transplant Registry 2002. National Renal Registry. Kuala Lumpur.

2. Academy of Medicine Malaysia. Malaysian Clinical practice Guideline for Diabetic Nephropathy. 2003.

3. Breyer JA. Diabetic nephropathy in insulin-dependent patients. Arm J Kidney Dis. 1992; 20: 533-47.

4. American Diabetic Association. Diabetic Nephropathy (Position Statement). Diabetes Care 2003; 26(Suppl.1): S94-8.

5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.

6. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin- dependent diabetes mellitus: a randomized prospective 6- year study. Diabetes Res Clin Pract 1995; 28: 103-17.

7. Peterson JC, Adler S. Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The modification of Diet in Renal Disease Study. Ann Intern Med 1995 123: 754-62.

8. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE and MICRO-HOPE substudy. Lancet 2000; 355: 253-9. [Erratum, Lancet 2000; 356: 860]

9. Brenner EM, Cooper ME, de Zeeuw D, et al. Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Eng J Med 2001; 345: 861-9.

10. Parving H-H, Lehnert H, Brochner-Mortensen J, Gomis R, Anderson S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Eng J Med 2001; 345: 870-8.

11. Alberti KCMM, Zimmet PZ. For the WHO Consultation; Definition, diagnosis and classification of diabetes mellitus, and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 1998; 15: 539-53.

12. The Asian-Pacific Type 2 Diabetes Policy Group. Type 2 Diabetes, Practical targets and treatments,3rd Ed. 2002:WHO. IDF.

13. Practise Guidelines for Diabetes Mellitus Type 2 (NIDDM), The Malaysian Consensus 2000. Kuala Lumpur: Ministry of Health Malaysia.

14. Clinical Practice Guidelines on the Management of Hypertension 2002. Kuala Lumpur: Ministry of Health Malaysia.

15. Consensus Statement on Management of Hyperlipidaemia. 2nd Edition. 2000. Kuala Lumpur: Ministry of Health Malaysia.

16. Schneid DC, McCarthy LH, Lawler FH, Hamm RM, Reily KE. Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence. J Fam Pract. 2001: 50(8): 661-8.

17. Wong JS, Rahimah N. Glycaemic control of diabetic patients in an urban primary health care setting in Sarawak: The Klinik Kesihatan Tanah Puteh experience. Med J Malaysia 2004: 59(3): 411-7.

18. Mattock MB, Moorish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992: 41: 736- 41.

19. Peterson JC; Adler S Burkart, JM et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Inter Med 1995; 123: 754-62.

20. Hansson L, Lindholm LH. Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999; 353: 611-6.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.